DXCM vs ELAN · P/E 63, rev $2.50B vs rev $2.74B
DexCom Inc (DXCM) versus Elanco Animal Health (ELAN) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Elanco Animal Health (ELAN) is a drug manufacturers - specialty & generic company listed on US.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported ELAN revenue for 2026-06-30 was $2.74B. Net income was $111.0M. Revenue was up 99.8% from 2026-03-31 to 2026-06-30. ELAN currently screens at market cap $11.80B.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. ELAN currently screens at market cap $11.80B.
Not investment advice. Open the DXCM and ELAN stock pages for the full models.
Not investment advice.